- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/58 - Plasminogen activators, e.g. urokinase, TPA
Patent holdings for IPC class C12N 15/58
Total number of patents in this class: 21
10-year publication summary
|
1
|
0
|
1
|
0
|
0
|
3
|
2
|
1
|
0
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Rin Institute Inc. | 26 |
3 |
| National Cancer Center | 407 |
2 |
| Trustees of Dartmouth College | 1078 |
2 |
| Talengen International Limited | 79 |
2 |
| Board of Regents, The University of Texas System | 5738 |
1 |
| Vertex Pharmaceuticals Incorporated | 1589 |
1 |
| Albert Einstein College of Medicine, Inc. | 571 |
1 |
| Alnylam Pharmaceuticals, Inc. | 1144 |
1 |
| Anhui New Star Pharmaceutical Development Co., Ltd. | 13 |
1 |
| Council of Scientific & Industrial Research | 1416 |
1 |
| Regents of the University of Minnesota | 2684 |
1 |
| Sirnaomics, Inc. | 111 |
1 |
| Sun Yat-sen University | 661 |
1 |
| University of Massachusetts | 2214 |
1 |
| University of North Texas | 202 |
1 |
| Shenzhen Blot Biotech Co., Ltd. | 13 |
1 |
| Other owners | 0 |